OPNT CEO Dr. Roger Crystal Discusses The State Of The Opioid Crisis

The CEO of Opiant Pharmaceuticals (OPNT), Dr. Roger Crystal, says that the company develops treatments for substance use, as well as addictive and eating disorders. Their breakthrough naloxone nasal spray treatments are FDA approved for treatment of opioid overdose. The stock is up 32% in 2021.

The Watch List

19 Apr 2021

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US

OPNT CEO Dr. Roger Crystal Discusses The State Of The Opioid Crisis

The CEO of Opiant Pharmaceuticals (OPNT), Dr. Roger Crystal, says that the company develops treatments for substance use, as well as addictive and eating disorders. Their breakthrough naloxone nasal spray treatments are FDA approved for treatment of opioid overdose. The stock is up 32% in 2021.

The Watch List

19 Apr 2021

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US